Versant Venture Management, LLC

13F Portfolio Filings

Most recent 13F
Q4 2023
Location
San Francisco, CA
CIK
0001560009
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q4 2023 7 388,843 RYZB, CRSP, RPTX, GRTS 13F-HR 2/8/2024 000095012324001156
Q3 2023 8 188,112 RYZB, RPTX, CRSP, ADVM 13F-HR 11/3/2023 000095012323009395
Q2 2023 8 84,298 RPTX, CRSP, ADVM, GRTS 13F-HR 8/9/2023 000095012323007098
Q1 2023 7 47,972 CRSP, GRTS, PASG, CBAY 13F-HR 5/10/2023 000095012323004367
Q4 2022 7 48,328 CRSP, GRTS, PASG, CBAY 13F-HR 2/9/2023 000095012323001275
Q3 2022 8 58,655 CRSP, GRTS, PASG, ADVM 13F-HR 11/10/2022 000095012322011472
Q2 2022 8 65,230 CRSP, PASG, GRTS, ADVM 13F-HR 8/11/2022 000095012322008452
Q1 2022 10 100,171 CRSP, PASG, GRTS, CRNX 13F-HR 5/10/2022 000095012322005030
Q4 2021 10 186,975 GRTS, CRSP, PASG, ALGS 13F-HR 2/11/2022 000095012322001851
Q3 2021 11 241,512 CRSP, PASG, GRTS, ALGS 13F-HR 11/12/2021 000095012321014984
Q2 2021 11 301,807 CRSP, PASG, ALGS, GRTS 13F-HR 8/12/2021 000095012321010561
Q1 2021 11 513,262 CRSP, PASG, ALGS, ADVM 13F-HR 5/6/2021 000095012321005457
Q4 2020 12 962,968 CRSP, NARI, ALGS, ADVM 13F-HR 2/16/2021 000095012321002373
Q3 2020 11 546,369 CRSP, ADVM, APRE, FLXN 13F-HR 11/12/2020 000095012320011532
Q2 2020 12 696,065 CRSP, ADVM, APRE, AKRO 13F-HR 7/20/2020 000110465920084768
Q1 2020 9 364,636 CRSP, ADVM, AKRO, VCYT 13F-HR 4/28/2020 000110465920052226
Q4 2019 7 331,845 CRSP, VCYT, GRTS, OCUL 13F-HR 1/21/2020 000110465920005491
Q3 2019 8 258,454 CRSP, VCYT, GRTS, BOLD 13F-HR 10/8/2019 000110465919053357
Q2 2019 9 343,186 CRSP, VCYT, GRTS, BOLD 13F-HR 7/12/2019 000110465919039996
Q1 2019 9 303,568 CRSP, VCYT, BOLD, CBAY 13F-HR 4/5/2019 000110465919020144
Q4 2018 10 202,020 CRSP, VCYT, BOLD, OCUL 13F-HR 1/22/2019 000110465919002754
Q3 2018 10 294,005 CRSP, BOLD, VCYT, OCUL 13F-HR 10/5/2018 000110465918060749
Q2 2018 9 320,525 CRSP, BOLD, OCUL, CBAY 13F-HR 7/13/2018 000110465918045045
Q1 2018 8 312,675 CRSP, BOLD, AKAOQ, OCUL 13F-HR 5/3/2018 000110465918030300
Q4 2017 7 95,029 BOLD, AKAOQ, OCUL, CBAY 13F-HR 1/25/2018 000110465918003973
Q3 2017 8 131,378 BOLD, IMDZ, AKAOQ, OCUL 13F-HR 10/13/2017 000110465917062084
Q2 2017 8 127,127 BOLD, AKAOQ, IMDZ, OCUL 13F-HR 8/2/2017 000110465917048730
Q1 2017 8 137,509 AKAOQ, BOLD, CLVSQ, OCUL 13F-HR 4/7/2017 000110465917022191
Q4 2016 7 102,740 BOLD, OCUL, CLVSQ, AKAOQ 13F-HR 1/18/2017 000110465917002761
Q3 2016 7 89,691 BOLD, IMDZ, OCUL, CLVSQ 13F-HR 10/24/2016 000110465916151423
Q2 2016 5 98,672 GKOS, OCUL, CLVSQ, AKAOQ 13F-HR 7/28/2016 000110465916135018
Q1 2016 7 138,515 GKOS, FPRX, OCUL, CLVSQ 13F-HR 4/25/2016 000110465916113751
Q4 2015 7 170,904 GKOS, FPRX, OCUL, CLVSQ RESTATEMENT 5/5/2016 000110465916118185
Q3 2015 7 174,363 GKOS, CLVSQ, OCUL, FPRX 13F-HR 10/28/2015 000110465915073439
Q2 2015 5 78,844 CLVSQ, FPRX, AKAOQ, Biotie Therapies Corp. 13F-HR 7/15/2015 000110465915051249
Q1 2015 6 113,697 CLVSQ, FPRX, AKAOQ, CBAY 13F-HR 4/23/2015 000110465915029755
Q4 2014 5 104,586 CLVSQ, FPRX, AKAOQ, CBAY RESTATEMENT 4/23/2015 000110465915029709
Additional filings from Versant Venture Management, LLC that have since been restated